Commonwealth Equity Services
BMY.RT

Commonwealth Equity Services’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Commonwealth Equity Services’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-123,227
Closed -$85K – 3509
2020
Q4 		$85K Sell
123,227
-12,841
-9% -$27.4K ﹤0.01% 3083
2020
Q3 		$306K Buy
136,068
+2,666
+2% +$7.61K ﹤0.01% 2343
2020
Q2 		$477K Buy
133,402
+15,145
+13% +$54.6K ﹤0.01% 1919
2020
Q1 		$449K Sell
118,257
-8,619
-7% -$28.4K ﹤0.01% 1766
2019
Q4 		$381K Buy
+126,876
New +$330K ﹤0.01% 2116

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Commonwealth Equity Services's BMY.RT Position: Q1 2021 in Review

Commonwealth Equity Services sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 123,227 shares — an estimated $85K sold.

Commonwealth Equity Services first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $477K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Commonwealth Equity Services reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Commonwealth Equity Services sold 123,227 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $85K.
  • Commonwealth Equity Services first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Commonwealth Equity Services's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $477K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Commonwealth Equity Services's 13F filing for Q1 2021, filed 4 May 2021.